![Logo of OpenAlex.org Project OpenAlex Citations Logo](https://www.oahelper.org/wp-content/plugins/oahelper-citations/img/logo-openalex.jpg)
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Quinoline‐based thiazolidinone derivatives as potent cytotoxic and apoptosis‐inducing agents through EGFR inhibition
Mohamed S. Nafie, Safaa M. Kishk, Sebaey Mahgoub, et al.
Chemical Biology & Drug Design (2021) Vol. 99, Iss. 4, pp. 547-560
Closed Access | Times Cited: 32
Mohamed S. Nafie, Safaa M. Kishk, Sebaey Mahgoub, et al.
Chemical Biology & Drug Design (2021) Vol. 99, Iss. 4, pp. 547-560
Closed Access | Times Cited: 32
Showing 1-25 of 32 citing articles:
4-Thiazolidinone-Bearing Hybrid Molecules in Anticancer Drug Design
Piotr Roszczenko, Serhii Holota, Olga Klaudia Szewczyk-Roszczenko, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 13135-13135
Open Access | Times Cited: 40
Piotr Roszczenko, Serhii Holota, Olga Klaudia Szewczyk-Roszczenko, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 13135-13135
Open Access | Times Cited: 40
Potent EGFR/PARP-1 inhibition by spirooxindole-triazole hybrids for targeted liver cancer therapy
Mohamed S. Nafie, M. Ali, Moayad Abdullah Alwehaibi, et al.
RSC Advances (2025) Vol. 15, Iss. 1, pp. 58-74
Open Access
Mohamed S. Nafie, M. Ali, Moayad Abdullah Alwehaibi, et al.
RSC Advances (2025) Vol. 15, Iss. 1, pp. 58-74
Open Access
One-Pot quaternization strategy for novel Poly(pyridinium-acetamide) ionic polymers as potential anticancer and anti-microbial agents
Salsabeel Al-Sodies, Mahmoud A. Hussein, Abdullah M. Asiri, et al.
European Polymer Journal (2025), pp. 113729-113729
Closed Access
Salsabeel Al-Sodies, Mahmoud A. Hussein, Abdullah M. Asiri, et al.
European Polymer Journal (2025), pp. 113729-113729
Closed Access
Synthesis of new functionalized bioactive S-substituted indolyl-triazoles as cytotoxic and apoptotic agents through multi-targeted kinase inhibition
Ahmed T. A. Boraei, Mohamed S. Nafie, Assem Barakat, et al.
Bioorganic Chemistry (2025) Vol. 156, pp. 108154-108154
Closed Access
Ahmed T. A. Boraei, Mohamed S. Nafie, Assem Barakat, et al.
Bioorganic Chemistry (2025) Vol. 156, pp. 108154-108154
Closed Access
Design and Synthesis of Topoisomerases-Histone Deacetylase Dual Targeted Quinoline-Bridged Hydroxamates as Anticancer Agents
Gaurav Joshi, Umesh Prasad Yadav, Zahid Rafiq, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Gaurav Joshi, Umesh Prasad Yadav, Zahid Rafiq, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Microwave-assisted synthesis and in vitro and in silico studies of pyrano[3,2-c]quinoline-3-carboxylates as dual acting anti-cancer and anti-microbial agents and potential topoisomerase II and DNA-gyrase inhibitors
Ashraf A. Aly, Hisham A. Abd El-Naby, Essam Kh. Ahmed, et al.
RSC Advances (2025) Vol. 15, Iss. 3, pp. 1941-1956
Open Access
Ashraf A. Aly, Hisham A. Abd El-Naby, Essam Kh. Ahmed, et al.
RSC Advances (2025) Vol. 15, Iss. 3, pp. 1941-1956
Open Access
Exploring pyrrolidinyl-spirooxindole natural products as promising platforms for the synthesis of novel spirooxindoles as EGFR/CDK2 inhibitors for halting breast cancer cells
Mohamed S. Nafie, Abdullah Mohammed Al‐Majid, M. Ajmal Ali, et al.
Frontiers in Chemistry (2024) Vol. 12
Open Access | Times Cited: 5
Mohamed S. Nafie, Abdullah Mohammed Al‐Majid, M. Ajmal Ali, et al.
Frontiers in Chemistry (2024) Vol. 12
Open Access | Times Cited: 5
Thiazolidinone‐Heterocycle Frameworks: A Concise Review of Their Pharmacological Significance
Pule Seboletswe, Nosipho Cele, Parvesh Singh
ChemMedChem (2023) Vol. 18, Iss. 7
Closed Access | Times Cited: 11
Pule Seboletswe, Nosipho Cele, Parvesh Singh
ChemMedChem (2023) Vol. 18, Iss. 7
Closed Access | Times Cited: 11
Synthesis, Characterization, and Cytotoxicity of New Spirooxindoles Engrafted Furan Structural Motif as a Potential Anticancer Agent
Mezna Saleh Altowyan, Saied M. Soliman, Matti Haukka, et al.
ACS Omega (2022) Vol. 7, Iss. 40, pp. 35743-35754
Open Access | Times Cited: 20
Mezna Saleh Altowyan, Saied M. Soliman, Matti Haukka, et al.
ACS Omega (2022) Vol. 7, Iss. 40, pp. 35743-35754
Open Access | Times Cited: 20
Design and synthesis of new bis(1,2,4-triazolo[3,4-b][1,3,4]thiadiazines) and bis((quinoxalin-2-yl)phenoxy)alkanes as anti-breast cancer agents through dual PARP-1 and EGFR targets inhibition
Fatma M. Thabet, Kamal M. Dawood, Eman A. Ragab, et al.
RSC Advances (2022) Vol. 12, Iss. 36, pp. 23644-23660
Open Access | Times Cited: 16
Fatma M. Thabet, Kamal M. Dawood, Eman A. Ragab, et al.
RSC Advances (2022) Vol. 12, Iss. 36, pp. 23644-23660
Open Access | Times Cited: 16
One-Pot Synthesis of 1-Thia-4-azaspiro[4.4/5]alkan-3-ones via Schiff Base: Design, Synthesis, and Apoptotic Antiproliferative Properties of Dual EGFR/BRAFV600E Inhibitors
Lamya H. Al-Wahaibi, Essmat M. El‐Sheref, Mohamed M. Hammouda, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 3, pp. 467-467
Open Access | Times Cited: 9
Lamya H. Al-Wahaibi, Essmat M. El‐Sheref, Mohamed M. Hammouda, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 3, pp. 467-467
Open Access | Times Cited: 9
Synthesis of phthalazine-based derivatives as selective anti-breast cancer agents through EGFR-mediated apoptosis: in vitro and in silico studies
Sara M. Emam, Samir M. El Rayes, Ibrahim A. I. Ali, et al.
BMC Chemistry (2023) Vol. 17, Iss. 1
Open Access | Times Cited: 9
Sara M. Emam, Samir M. El Rayes, Ibrahim A. I. Ali, et al.
BMC Chemistry (2023) Vol. 17, Iss. 1
Open Access | Times Cited: 9
Synthesis of novel phthalazine-based derivatives with potent cytotoxicity against HCT-116 cells through apoptosis and VEGFR2 inhibition
Donia El Sayed, Samir M. El Rayes, Hamdy A.M. Soliman, et al.
RSC Advances (2024) Vol. 14, Iss. 19, pp. 13027-13043
Open Access | Times Cited: 2
Donia El Sayed, Samir M. El Rayes, Hamdy A.M. Soliman, et al.
RSC Advances (2024) Vol. 14, Iss. 19, pp. 13027-13043
Open Access | Times Cited: 2
Synthesis, characterization and biological research of novel 2-(quinoline-4-carbonyl)hydrazide-acrylamide hybrids as potential anticancer agents on MCF-7 breast carcinoma cells by targeting EGFR-TK
Hany M. Abd El‐Lateef, Duaa Bafail, Noura Hamdi Yousef Alhalees, et al.
RSC Advances (2024) Vol. 14, Iss. 32, pp. 23495-23504
Open Access | Times Cited: 2
Hany M. Abd El‐Lateef, Duaa Bafail, Noura Hamdi Yousef Alhalees, et al.
RSC Advances (2024) Vol. 14, Iss. 32, pp. 23495-23504
Open Access | Times Cited: 2
Synthesis of novel piperazine-based bis(thiazole)(1,3,4-thiadiazole) hybrids as anti-cancer agents through caspase-dependent apoptosis
Doaa M. Mohamed, Nabila A. Kheder, Marwa Sharaky, et al.
RSC Advances (2024) Vol. 14, Iss. 34, pp. 24992-25006
Open Access | Times Cited: 2
Doaa M. Mohamed, Nabila A. Kheder, Marwa Sharaky, et al.
RSC Advances (2024) Vol. 14, Iss. 34, pp. 24992-25006
Open Access | Times Cited: 2
Identification of indole-grafted pyrazolopyrimidine and pyrazolopyridine derivatives as new anti-cancer agents: Synthesis, biological assessments, and molecular modeling insights
Wagdy M. Eldehna, Haytham O. Tawfik, Maha-Hamadien Abdulla, et al.
Bioorganic Chemistry (2024) Vol. 153, pp. 107804-107804
Closed Access | Times Cited: 2
Wagdy M. Eldehna, Haytham O. Tawfik, Maha-Hamadien Abdulla, et al.
Bioorganic Chemistry (2024) Vol. 153, pp. 107804-107804
Closed Access | Times Cited: 2
Unveiling the anti-cancer potentiality of phthalimide-based Analogues targeting tubulin polymerization in MCF-7 cancerous Cells: Rational design, chemical Synthesis, and Biological-coupled Computational investigation
Ateyatallah Aljuhani, Mohamed S. Nafie, Nader R. Albujuq, et al.
Bioorganic Chemistry (2024) Vol. 153, pp. 107827-107827
Closed Access | Times Cited: 2
Ateyatallah Aljuhani, Mohamed S. Nafie, Nader R. Albujuq, et al.
Bioorganic Chemistry (2024) Vol. 153, pp. 107827-107827
Closed Access | Times Cited: 2
Quinoline–hydrazone hybrids as dual mutant EGFR inhibitors with promising metallic nanoparticle loading: rationalized design, synthesis, biological investigation and computational studies
Ranza Elrayess, Khaled M. Darwish, Mohamed S. Nafie, et al.
New Journal of Chemistry (2022) Vol. 46, Iss. 38, pp. 18207-18232
Closed Access | Times Cited: 9
Ranza Elrayess, Khaled M. Darwish, Mohamed S. Nafie, et al.
New Journal of Chemistry (2022) Vol. 46, Iss. 38, pp. 18207-18232
Closed Access | Times Cited: 9
Integration of proteomics and network toxicology reveals the mechanism of mercury chloride induced hepatotoxicity, in mice and HepG2 cells
Xin Cao, Kanmin Mao, Yanan Zhang, et al.
Food and Chemical Toxicology (2023) Vol. 177, pp. 113820-113820
Closed Access | Times Cited: 5
Xin Cao, Kanmin Mao, Yanan Zhang, et al.
Food and Chemical Toxicology (2023) Vol. 177, pp. 113820-113820
Closed Access | Times Cited: 5
Fragment-based design and synthesis of coumarin-based thiazoles as dual c-MET/STAT-3 inhibitors for potential antitumor agents
Bassem H. Naguib, Heba A. Elsebaie, Mohamed S. Nafie, et al.
Bioorganic Chemistry (2024) Vol. 151, pp. 107682-107682
Closed Access | Times Cited: 1
Bassem H. Naguib, Heba A. Elsebaie, Mohamed S. Nafie, et al.
Bioorganic Chemistry (2024) Vol. 151, pp. 107682-107682
Closed Access | Times Cited: 1
Rational Design, Synthesis and Biological Evaluation of Novel Pyrazoline-Based Antiproliferative Agents in MCF-7 Cancer Cells
Mariam M. Fakhry, Kazem Mahmoud, Mohamed S. Nafie, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 10, pp. 1245-1245
Open Access | Times Cited: 9
Mariam M. Fakhry, Kazem Mahmoud, Mohamed S. Nafie, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 10, pp. 1245-1245
Open Access | Times Cited: 9
Design, Synthesis, Anticancer Evaluation and Molecular Modeling Studies of New Thiazolidinone‐Benzoate Scaffold as EGFR Inhibitors, Cell Cycle Interruption and Apoptosis Inducers in HepG2
Salwa Magdy Eldaly, Dalia Salama Zakaria, Nadia H. Metwally
Chemistry & Biodiversity (2023) Vol. 20, Iss. 10
Closed Access | Times Cited: 4
Salwa Magdy Eldaly, Dalia Salama Zakaria, Nadia H. Metwally
Chemistry & Biodiversity (2023) Vol. 20, Iss. 10
Closed Access | Times Cited: 4
New spiro-indeno[1,2- b ]quinoxalines clubbed with benzimidazole scaffold as CDK2 inhibitors for halting non-small cell lung cancer; stereoselective synthesis, molecular dynamics and structural insights
Assem Barakat, Saeed Alshahrani, Abdullah Mohammed Al‐Majid, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 4
Assem Barakat, Saeed Alshahrani, Abdullah Mohammed Al‐Majid, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 4
Recruitment of hexahydroquinoline as anticancer scaffold targeting inhibition of wild and mutants EGFR (EGFR WT , EGFR T790M , and EGFR L858R )
Mahmoud G. Abo Al-Hamd, Haytham O. Tawfik, Omeima Abdullah, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 3
Mahmoud G. Abo Al-Hamd, Haytham O. Tawfik, Omeima Abdullah, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 3
GC-MS/MS Quantification of EGFR Inhibitors, β-Sitosterol, Betulinic Acid, (+) Eriodictyol, (+) Epipinoresinol, and Secoisolariciresinol, in Crude Extract and Ethyl Acetate Fraction of Thonningia sanguinea
Sameh S. Elhady, El-Sayed Ibrahim, Marwa S. Goda, et al.
Molecules (2022) Vol. 27, Iss. 13, pp. 4109-4109
Open Access | Times Cited: 6
Sameh S. Elhady, El-Sayed Ibrahim, Marwa S. Goda, et al.
Molecules (2022) Vol. 27, Iss. 13, pp. 4109-4109
Open Access | Times Cited: 6